Foundation Venture Capital Group, LLC
Impact investorPrinceton · Pre-Seed–Series A · 14 people tracked
Investment thesis
Foundation Venture Capital Group practices impact investing focused on New Jersey's health-related technology sector. It provides pre-seed and seed capital to early-stage startups emerging from affiliated research organizations, aiming to generate measurable social impact while advancing innovations toward commercialization. Beyond capital, it offers nonmonetary support including strategic, operational, and back-office assistance beginning before incorporation and continuing through the company's life cycle until traditional venture funding becomes viable. Gains from investments are reinvested to fund further research and innovation at affiliated organizations. The firm also helps portfolio companies connect with traditional venture capital partners to further commercialize their discoveries for patient benefit.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & public directoriesWhat they invest in
from 5 of 13 portfolio companiesBiotech ×5Healthtech ×4AI & Machine Learning ×1Digital Health ×1Medical Devices ×1New Materials ×1
HQs:United States×2
Investments · 13 tracked
founders shown can be your intro pathNovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries.
BiotechHealthtechMedical DevicesMonmouth Junction, US
Charles J. Gatt, Jr., MD(Founder & CEO)Michael G. Dunn, PhD(Founder & Secretary/Treasurer)Kevin Weadock, PhD(Chief Operating Officer)
Biopharmaceutical company developing Leukothera-based therapeutics for blood cancers, autoimmune/inflammatory diseases, and HIV.
Developing blood tests to detect neurodegenerative diseases at early stages; Foundation sold its equity interest to Breakthrough Diagnostics, LLC.
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease.
AI & Machine LearningBiotechDigital Health
First spin-out from Hackensack Meridian Health Research Institute, developing a platform for targeted capture of extracellular vesicles to enable earlier detection of tumors and other diseases.
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Thong Le(Executive Officer, Director)Kendall Mohler(Executive Officer, Director)Mark Esposito(CSO, Co-Founder and Board Member)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)
Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
Repurposing a clinically approved drug to treat L-Dopa Induced Dyskinesia in Parkinson's disease patients.
Spinout of Cooper University HealthCare developing a multi-directional vascular access system enabling antegrade and retrograde access through a single entry point.
Mattek develops in vitro life science technologies, including lab-grown 3D human epithelial tissue models, banks of primary human cells, and cell culture dishes and plates ("Cultureware") designed for cell growth and imaging.
BiotechHealthtechNew Materials
Michael Johnson(Cofounder)
Designs mental health and addiction medications aimed at minimizing misuse and preventing overdose fatalities.
Frequently asked questions
- What stage does Foundation Venture Capital Group, LLC invest at?
- Foundation Venture Capital Group, LLC invests at the Pre-Seed, Seed, Series A stages.
- What is Foundation Venture Capital Group, LLC's typical check size?
- Foundation Venture Capital Group, LLC typically writes checks of $500K.
- What sectors does Foundation Venture Capital Group, LLC focus on?
- Foundation Venture Capital Group, LLC focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices, Mental Health.
- Where is Foundation Venture Capital Group, LLC located?
- Foundation Venture Capital Group, LLC is headquartered in Princeton, US.
Similar investors
Serendipity Impact VC is an early-stage venture firm backing founders building breakthrough technologies for mental and neuro health, with roots in the Israeli innovation ecosystem and a focus on the U.S. market.
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Everywhere Ventures is an early-stage venture firm that backs founders globally, supported by a community of founders and operators as LPs.
HealthQuad is a healthcare-focused venture capital fund in India that partners with entrepreneurs building innovative, category-defining healthcare businesses across the healthcare value chain.
Equitage Ventures invests in early-stage companies addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.